Douglas Elliman
DOUG · NYSE
About DOUG
- Employees
- 580
- Headquarters
- Miami, Florida
- Listed
- Dec 17, 2021
- Sector
- Real Estate
- Industry
- Real Estate Management & Development
- Website
- investors.elliman.com
DOUG key statistics
- Market cap
- 131.79M
- Price-earnings ratio
- 4.83
- Dividend yield
- —
- Average volume
- 565.32K
- Volume
- 422.26K
- Open price
- $1.40
- High today
- $1.47
- Low today
- $1.38
- 52 Week high
- $3.03
- 52 Week low
- $1.40
Douglas Elliman (DOUG) at a glance
Douglas Elliman (DOUG) last traded at $1.45, with a market cap of 131.79M and a price-to-earnings ratio of 4.83.
Today the stock has traded between $1.38 and $1.47. The current price is 5.1% above the day's low and 1.4% below its high.
Volume so far is 422.26K shares, below the average of 565.32K shares a day.
Over the past year Douglas Elliman has ranged from $1.40 to $3.03, and now sits 3% of the way up that range.
Douglas Elliman met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q4 FY25 it reported -$0.17 per share against an estimate of $0.0306.
The average analyst price target is $3.26, 125.1% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $3.23
- Now
- $1.45
- High
- $3.36
DOUG earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 149.0% on average.
- Q4 FY23: reported -$0.18 per share against an estimate of -$0.0796
- Q4 FY24: reported $0.03 per share against an estimate of -$0.0612
- Q1 FY24: reported -$0.50 per share against an estimate of -$0.0724
- Q2 FY24: reported -$0.02 per share against an estimate of -$0.0051
- Q3 FY24: reported -$0.09 per share against an estimate of -$0.0408
- Q2 FY25: reported -$0.06 per share against an estimate of $0.0204
- Q3 FY25: reported $0.00 per share against an estimate of $0.0306
- Q4 FY25: reported -$0.17 per share against an estimate of $0.0306
DOUG news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Douglas Elliman Inc. to Host Second Quarter 2026 Results Conference Call
- Press releasePRNewswire
DOUGLAS ELLIMAN LAUNCHES AI TRANSFORMATION BUILT WITH GOOGLE CLOUD'S TECHNOLOGY, UNVEILS NEW INTELLIGENCE COMPANY, AND ANNOUNCES DRIVE TO RESET COST STRUCTURE
- Press releasePRNewswire
Douglas Elliman Celebrates the Return of the U.S. Open to the Hamptons
- Press releasePRNewswire
Douglas Elliman Expands to Paris
- Press releasePRNewswire
Casa Avenida Celebrates Official Groundbreaking in Downtown Delray Beach
- Press releasePRNewswire
Douglas Elliman Expands Mortgage Platform Elliman Capital to California
- Press releaseBusiness Wire
Douglas Elliman Inc. Reports First Quarter 2026 Financial Results
Similar companies
Companies in the same industry as Douglas Elliman
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.